Skip to content

Comparison of USG- Guided Modified Pectoral Nerve Block and Erector Spinae Plane Block on Postoperative Analgesia in Video Assisted Thoracoscopic Surgery

The Effect of USG- Guided Modified Pectoral Nerve Block and Erector Spinae Plane Block on Postoperative Analgesia in Video Assisted Thoracoscopic Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04886375
Enrollment
55
Registered
2021-05-14
Start date
2019-04-01
Completion date
2020-04-01
Last updated
2021-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Analgesia, Video-assisted Thoracoscopic Surgery

Brief summary

This study aims to compare the effects of the erector spinae plan block (ESP) and modified pectoral nerve block (PECS II) on postoperative analgesia in patients undergoing video- assisted thoracoscopic surgery (VATS).

Detailed description

55 patients (ASA I-II-III) between 18 and 65 years of age, who were to undergo VATS, were randomized and divided into two groups. (26 patients in each of the PECS and ESP groups). Three patients were excluded from the study because thoracotomy was performed. ESP block was performed for ESP group and a modified pectoral nerve block was performed in the PECS group. Postoperative analgesia was provided by intravenous morphine infusion using a patient-controlled analgesia device. Postoperative 24-hour total morphine consumption and duration of analgesia were the primary outcome measure. Perioperative remifentanil use, numeric rating scale values, time of the first analgesic request, and additional analgesic consumption were recorded.

Interventions

The investigators performed erector spina plane block to that patient group for postoperative analgesia

PROCEDUREmodified pectoral nerve block

The investigators performed modified pectoral block to that patient group for postoperative analgesia

Sponsors

Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Ages of 18-65 * Patients who will undergo VATS * ASA I-II-III patients

Exclusion criteria

* Clinically diagnosis of spinal or chest wall deformity or pathology * Clinically known local anesthetic allergy * Morbid obesity (body mass index\>40 kg m2) * Clinically diagnosis of opioid, alcohol and substance dependence * Clinically diagnosis of psychiatric disease * Coagulopathy * Patients with ASA IV-V

Design outcomes

Primary

MeasureTime frameDescription
Postoperative 24-hours total morphine consumption24 hours postoperativelyThis will be measured only one time by pca device at the 24th hour after surgery.

Secondary

MeasureTime frameDescription
NRS scores of patients24 hours postoperativelyNRS at 0, 1, 2, 4, 8, 12 ve 24th hours

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026